Hepion Pharmaceuticals Statistics
Total Valuation
HEPA has a market cap or net worth of 686,093. The enterprise value is -171,517.
| Market Cap | 686,093 |
| Enterprise Value | -171,517 |
Important Dates
The last earnings date was Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HEPA has 11.43 million shares outstanding. The number of shares has increased by 3,704.83% in one year.
| Current Share Class | 11.43M |
| Shares Outstanding | 11.43M |
| Shares Change (YoY) | +3,704.83% |
| Shares Change (QoQ) | +299.34% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 1.80% |
| Float | 10.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.18 |
| P/TBV Ratio | 0.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.01 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.60, with a Debt / Equity ratio of 0.10.
| Current Ratio | 7.60 |
| Quick Ratio | 4.93 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.31 |
Financial Efficiency
Return on equity (ROE) is -368.59% and return on invested capital (ROIC) is -131.33%.
| Return on Equity (ROE) | -368.59% |
| Return on Assets (ROA) | -98.47% |
| Return on Invested Capital (ROIC) | -131.33% |
| Return on Capital Employed (ROCE) | -211.72% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -616,448 |
| Employee Count | 22 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.82% in the last 52 weeks. The beta is 1.52, so HEPA's price volatility has been higher than the market average.
| Beta (5Y) | 1.52 |
| 52-Week Price Change | -99.82% |
| 50-Day Moving Average | 0.06 |
| 200-Day Moving Average | 9.87 |
| Relative Strength Index (RSI) | 50.52 |
| Average Volume (20 Days) | 364,295 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.28M |
| Pretax Income | -13.56M |
| Net Income | -13.56M |
| EBITDA | -8.27M |
| EBIT | -8.28M |
| Earnings Per Share (EPS) | -3.73 |
Balance Sheet
The company has 2.92 million in cash and 371,661 in debt, giving a net cash position of 2.55 million or 0.22 per share.
| Cash & Cash Equivalents | 2.92M |
| Total Debt | 371,661 |
| Net Cash | 2.55M |
| Net Cash Per Share | 0.22 |
| Equity (Book Value) | 3.80M |
| Book Value Per Share | 0.18 |
| Working Capital | 3.91M |
Cash Flow
| Operating Cash Flow | -6.16M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HEPA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3,704.83% |
| Shareholder Yield | n/a |
| Earnings Yield | -1,976.68% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 18, 2025. It was a reverse split with a ratio of 0.02.
| Last Split Date | Mar 18, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.02 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |